Adaptimmune Therapeutics
ADAP
#9324
Rank
โ‚ฌ60.56 M
Marketcap
0,24ย โ‚ฌ
Share price
-20.31%
Change (1 day)
-81.36%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Net assets

Net assets on the balance sheet as of December 2024 : โ‚ฌ10.8 Million

According to Adaptimmune Therapeutics's latest financial reports the company has โ‚ฌ10.8 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Adaptimmune Therapeutics - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚ฌ35.74 M-53.17%
2022-12-31$โ‚ฌ76.33 M-58.03%
2021-12-31$โ‚ฌ0.18 B-34.45%
2020-12-31$โ‚ฌ0.27 B151.36%
2019-12-31$โ‚ฌ0.11 B-48.86%
2018-12-31$โ‚ฌ0.21 B27.57%
2017-12-31$โ‚ฌ0.16 B7.1%
2016-12-31$โ‚ฌ0.15 B
2015-06-30$โ‚ฌ0.23 B12965.85%
2014-06-30$โ‚ฌ1.76 M-206.6%
2013-06-30$-โ‚ฌ1.66 Million1569.13%
2012-06-30$-โ‚ฌ0.1 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-โ‚ฌ0.57 Billion-5,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.52 M 293.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.16 Million-156.98%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ2.04 B 18,839.99%๐Ÿ‡บ๐Ÿ‡ธ USA